Search
for
Sort by
Research 61–90 of 1000+
- 5% Minoxidil topical foam for men: Hair growth in millennials – a post hoc analysis
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- 5% Minoxidil topical foam on women: Menopause and other covariates
- Alopecia in patients treated with molecularly targeted anticancer therapies
- c-Kit - The Novel Receptor: Physiological Roles, Downstream Signaling and Implications in Cancer
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management
- Incidence of alopecia from endocrine therapies in cancer
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Getting to grips with hair loss
- Male hormonal contraception: looking back and moving forward
- Men??s Health
- Macrophages in Skin Wounds: Functions and Therapeutic Potential
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- A Comprehensive Review of Acne Treatments: Unpacking the Chemical Structures and Effective Bioactive Compounds
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Anthracycline analogs The past, present, and future
- The Enticing Path of miR Therapeutics: Difficult but Not without Prospects
- Non-hemorrhage-related adverse effects of rivaroxaban
- Calcipotriene plus betamethasone dipropionate gel: a new combination therapy for scalp psoriasis
- Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Enhancing dermatology clinical trials: optimizing sites and strategies for success in India
- Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study
- Efficacy and safety of a dietary supplement containing a lipid co-extract from Serenoa repens and Pygeum africanum for the treatment of androgenetic alopecia (AGA) in women. Results of a randomized, double-blind, placebo-controlled clinical trial
- 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)